Kolexia
Passot Christophe Pharmacien
Passot Christophe
Pharmacien
Ico - Site Paul Papin
Angers, France
42 Activités
123 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs colorectales Métastase tumorale Néphrocarcinome Arthrite Polyarthrite rhumatoïde Tumeurs du péritoine Tumeurs gastro-intestinales Tumeurs du sein

Collaborateurs

Voir plus
Paintaud Gilles
Paintaud Gilles
Centre hospitalier de Tours, Tours, France
Ternant David
Ternant David
Centre hospitalier de Tours, Tours, France
Mulleman Denis
Mulleman Denis
Centre hospitalier de Tours, Tours, France
Bejan Angoulvant Theodora
Bejan Angoulvant Theodora
Centre hospitalier de Tours, Tours, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.
British journal of clinical pharmacology   19 février 2024
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
Journal for immunotherapy of cancer   09 novembre 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.
Clinical pharmacokinetics   13 juillet 2023
AXIPAP: Multicenter Phase II Study of Axitinib in First Line Treatment for Patients With Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC)
Essai Clinique (Centre Léon-Bérard)   01 septembre 2022
PIPOX: Phase I / II Dose Escalation of Oxaliplatin Via a Laparoscopic Approach of Aerosol Pressurized Intraperitoneal Chemotherapy for Nonresectable Peritoneal Metastases of Digestive Cancers (Stomach, Hail and Colorectal)
Essai Clinique (Institut Cancerologie de l'Ouest)   19 avril 2022
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
Genome medicine   09 novembre 2021
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model.
Pharmaceutics   01 novembre 2021
425P Cetuximab could be administered once every two weeks instead of once weekly
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model.
Clinical pharmacokinetics   05 août 2021
A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'.
European journal of cancer (Oxford, England : 1990)   12 février 2021